Discovery of a Novel, Selective and Irreversible Inhibitor (Abivertinib) of Mutated EGFR and T790M-induced Resistance for the Treatment of NSCLC

by Long Mao, Wei Tang, Xiaoying Zhang, Jia Liu, Yile Chen, Yuning Hua, Bojie Weng, Xiaopeng Mo, Yimei Bao, Li Teng, Lijun Xu, Yuren Zhang, Jian Wu, Guanglin Zhou, Bin Liang, Changxu Xu, Biao Xi, Li Zhao, Rongda Xu, Che Fang, Wanhong Xu, Xiaobo Wang, Xiao Xu
Published 2020-06-01